[1]
A. Gottlieb, M. Lebwohl, A. Armstrong, R. Israel, and A. Jacobson, “Malignancy Events in Patients With a History of Cancer in Clinical Studies of Brodalumab”, J of Skin, vol. 4, no. 1, p. S23, Jan. 2020.